Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_3
1
33%
Ph phase_1
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 11 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)

Trials by Status

unknown133%
withdrawn133%
not_yet_recruiting133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingphase_1

Neuromodulation in Patients With Pulmonary Arterial Hypertension

NCT06802380
withdrawnphase_3

Vagal Nerve Stimulation as an Alternative Therapy for Premature Ventricular Contractions

NCT06110364
unknownnot_applicable

LLTS to Treat Premature Ventricular Contractions

NCT04909528

Clinical Trials (3)

Showing 3 of 3 trials
NCT06802380Phase 1

Neuromodulation in Patients With Pulmonary Arterial Hypertension

Not Yet Recruiting
NCT06110364Phase 3

Vagal Nerve Stimulation as an Alternative Therapy for Premature Ventricular Contractions

Withdrawn
NCT04909528Not Applicable

LLTS to Treat Premature Ventricular Contractions

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3